[Therapeutic measures in recurrent calcium oxalate nephrolithiasis].
D001581:Benzothiadiazines; D002118:Calcium / Q000378:metabolism*; D002482:Cellulose / Q000627:therapeutic use; D004035:Diet Therapy; D011756:Diphosphates / Q000378:metabolism; D004232:Diuretics; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007474:Ion Exchange; D010710:Phosphates / Q000627:therapeutic use; D012008:Recurrence; D012964:Sodium / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014545:Urinary Calculi / Q000628:therapy*
D001581:Benzothiadiazines; D011756:Diphosphates; D004232:Diuretics; D010710:Phosphates; D049993:Sodium Chloride Symporter Inhibitors; D002482:Cellulose; D012964:Sodium; D002118:Calcium
Therapeutische Massnahmen bei rezidivierender Calcium-Oxalat-Nephrolithiasis.